Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Budget Impact Analysis for Peginterferon Beta-1a In Relapsing Remitting Multiple Sclerosis In Italy.
Axon initial segment-associated microglia.
MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study.
Intrathecal BCR transcriptome in multiple sclerosis versus other neuroinflammation: Equally diverse and compartmentalized, but more mutated, biased and overlapping with the proteome.
Tuftsin-driven experimental autoimmune encephalomyelitis recovery requires neuropilin-1.
Offspring Number Does Not Influence Reaching the Disability's Milestones in Multiple Sclerosis: A Seven-Year Follow-Up Study.
Revisiting adult neurogenesis and the role of erythropoietin for neuronal and oligodendroglial differentiation in the hippocampus.
Epigenetic Drugs for Multiple Sclerosis.
Elevation of AQP4 and selective cytokines in experimental autoimmune encephalitis mice provides some potential biomarkers in optic neuritis and demyelinating diseases.
Neurological Dysfunction in Early Maturity of a Model for Niemann-Pick C1 Carrier Status.
The multifaceted role of astrocytes in regulating myelination.
Complement Receptor 2 is increased in cerebrospinal fluid of multiple sclerosis patients and regulates C3 function.
Amyotrophic lateral sclerosis is not linked to multiple sclerosis in a population based study.
[Neurological complications during treatment of the tumor necrosis alpha inhibitors].
Comment and reply on:Emerging role of Th22 and IL-22 in multiple sclerosis, an autoimmune disease in the central nervous system.
The Urine Proteome Profile Is Different in Neuromyelitis Optica Compared to Multiple Sclerosis: A Clinical Proteome Study.
Effectiveness of muscle basal lamina carrying neural stem cells and olfactory ensheathing cells in spinal cord repair.
Undiagnosed neurological disease as a potential cause of male lower urinary tract symptoms.
Imaging gray matter with concomitant null point imaging from the phase sensitive inversion recovery sequence.
Hand grip fatigability in persons with multiple sclerosis according to hand dominance and disease progression.
Myelinating cocultures of rat retinal ganglion cell reaggregates and optic nerve oligodendrocyte precursor cells.
Nonapoptotic and Extracellular Activity of Granzyme B Mediates Resistance to Regulatory T Cell (Treg) Suppression by HLA-DR-CD25hiCD127lo Tregs in Multiple Sclerosis and in Response to IL-6.
Glial metabotropic glutamate receptor-4 increases maturation and survival of oligodendrocytes.
Corticospinal tract integrity is related to primary motor cortex thinning in relapsing-remitting multiple sclesis.
Decreased concentration of Klotho in the cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis.
Pages
« first
‹ previous
…
629
630
631
632
633
634
635
636
637
…
next ›
last »